{"id":"https://openalex.org/W4310103494","doi":"https://doi.org/10.1182/blood-2022-160304","title":"Multi-Omic Single-Cell Sequencing Reveals Genetic and Immunophenotypic Clonal Selection in Patients With FLT3-Mutated AML Treated With Gilteritinib/Venetoclax","display_name":"Multi-Omic Single-Cell Sequencing Reveals Genetic and Immunophenotypic Clonal Selection in Patients With FLT3-Mutated AML Treated With Gilteritinib/Venetoclax","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310103494","doi":"https://doi.org/10.1182/blood-2022-160304"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-160304","doi":"https://doi.org/10.1182/blood-2022-160304","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-160304","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090273676","display_name":"Vanessa Elaine Kennedy","orcid":"https://orcid.org/0000-0002-1912-4076","observed_orcids":["https://orcid.org/0000-0002-1912-4076"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vanessa E. Kennedy","raw_affiliation_strings":["1University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034417710","display_name":"Cheryl A.C. Peretz","orcid":"https://orcid.org/0000-0002-0855-6770","observed_orcids":["https://orcid.org/0000-0002-0855-6770"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheryl Peretz","raw_affiliation_strings":["2Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070015133","display_name":"Paul P. Lee","orcid":"https://orcid.org/0000-0002-3338-136X","observed_orcids":["https://orcid.org/0000-0002-3338-136X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Lee","raw_affiliation_strings":["3AbbVie, Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AbbVie, Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066196706","display_name":"Brenda Chyla","orcid":"https://orcid.org/0000-0003-2594-9696","observed_orcids":["https://orcid.org/0000-0003-2594-9696"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda Chyla","raw_affiliation_strings":["4AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090765795","display_name":"Yan Sun","orcid":"https://orcid.org/0000-0001-8706-3669","observed_orcids":["https://orcid.org/0000-0001-8706-3669"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Sun","raw_affiliation_strings":["4AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089772256","display_name":"Monique Dail","orcid":"https://orcid.org/0000-0002-2687-8829","observed_orcids":["https://orcid.org/0000-0002-2687-8829"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":null,"type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Monique Dail","raw_affiliation_strings":["5Genentech Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Genentech Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063166319","display_name":"Jason E. Hill","orcid":"https://orcid.org/0000-0003-2512-1661","observed_orcids":["https://orcid.org/0000-0003-2512-1661"]},"institutions":[{"id":"https://openalex.org/I4210165171","display_name":"Astellas Pharma (United States)","ror":"https://ror.org/05pw69n24","country_code":"US","type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4210165171"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Hill","raw_affiliation_strings":["6Astellas Pharma Global Development, Northbrook, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Astellas Pharma Global Development, Northbrook, IL","institution_ids":["https://openalex.org/I4210165171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021636620","display_name":"Elaine Tran","orcid":"https://orcid.org/0009-0000-5370-7788","observed_orcids":["https://orcid.org/0009-0000-5370-7788"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elaine Tran","raw_affiliation_strings":["1University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004828733","display_name":"Andrew Koh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Koh","raw_affiliation_strings":["1University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025780450","display_name":"Jessica Kaplan Altman","orcid":"https://orcid.org/0000-0003-1987-1896","observed_orcids":["https://orcid.org/0000-0003-1987-1896"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica K. Altman","raw_affiliation_strings":["7Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naval Daver","raw_affiliation_strings":["8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089694123","display_name":"Mark J. Levis","orcid":"https://orcid.org/0000-0003-0473-6982","observed_orcids":["https://orcid.org/0000-0003-0473-6982","https://orcid.org/0000-0003-4219-6315"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark J. Levis","raw_affiliation_strings":["9Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006561610","display_name":"James K. McCloskey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James McCloskey","raw_affiliation_strings":["10John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037460404","display_name":"Alexander E. Perl","orcid":"https://orcid.org/0000-0002-1463-2231","observed_orcids":["https://orcid.org/0000-0002-1463-2231"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Perl","raw_affiliation_strings":["11Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091814150","display_name":"Catherine Choy Smith","orcid":"https://orcid.org/0000-0003-0160-7026","observed_orcids":["https://orcid.org/0000-0003-0160-7026"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Smith","raw_affiliation_strings":["1University of California San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.7827,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.73559295,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"2244","last_page":"2246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-cell-multi-omics","display_name":"single-cell multi-omics","score":0.7480000257492065},{"id":"https://openalex.org/keywords/flt3-mutated-acute-myeloid-leukemia","display_name":"FLT3-mutated acute myeloid leukemia","score":0.9079999923706055},{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.859000027179718},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.9079999923706055},{"id":"https://openalex.org/keywords/clonal-selection","display_name":"clonal selection","score":0.6819999814033508},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5720000267028809},{"id":"https://openalex.org/keywords/ras-pathway-mutations","display_name":"RAS pathway mutations","score":0.6899999976158142},{"id":"https://openalex.org/keywords/idh2-mutation","display_name":"IDH2 mutation","score":0.7889999747276306},{"id":"https://openalex.org/keywords/dnmt3a","display_name":"DNMT3A","score":0.5690000057220459},{"id":"https://openalex.org/keywords/npm1","display_name":"NPM1","score":0.5569999814033508},{"id":"https://openalex.org/keywords/tet2","display_name":"TET2","score":0.6039999723434448},{"id":"https://openalex.org/keywords/ezh2","display_name":"EZH2","score":0.8809999823570251},{"id":"https://openalex.org/keywords/wt1","display_name":"WT1","score":0.8960000276565552},{"id":"https://openalex.org/keywords/nras","display_name":"NRAS","score":0.8119999766349792},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8205190300941467},{"id":"https://openalex.org/C113968399","wikidata":"https://www.wikidata.org/wiki/Q7559241","display_name":"Somatic evolution in cancer","level":3,"score":0.5525696277618408},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49159368872642517},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.4374951422214508},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.41340500116348267},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3930152654647827},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33095794916152954},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.32566988468170166},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.28325775265693665},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.25324010848999023},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15738961100578308},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.12361094355583191},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-160304","doi":"https://doi.org/10.1182/blood-2022-160304","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-160304","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6499999761581421,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2791038413","https://openalex.org/W4234339317","https://openalex.org/W3080900421","https://openalex.org/W4384199484","https://openalex.org/W3179857300","https://openalex.org/W2584413057","https://openalex.org/W3214672817","https://openalex.org/W4389467983","https://openalex.org/W4225091882","https://openalex.org/W3097526119"],"abstract_inverted_index":{"Background:":[0],"The":[1],"combination":[2],"of":[3,38,81,164,217,284,301,366,514,536,544,553,562,569,588],"the":[4,9,102,204,220,235,321,335,353,385,534,576,586],"FLT3":[5,258,383],"inhibitor":[6,11],"gilteritinib":[7],"with":[8,95,99,139,159,192,209,214,271,298,334,346,382,433,483,499,522,542,581,609],"BCL-2":[10],"venetoclax":[12],"(VenGilt)":[13],"is":[14,620,625],"highly":[15,527],"efficacious":[16],"in":[17,244,266,331,375,384,389,452,533,565],"relapsed/refractory":[18],"(R/R)":[19],"FLT3-mutated":[20,530,577,603],"acute":[21],"myeloid":[22],"leukemia":[23],"(AML).":[24],"In":[25,200,211,289,318,392],"a":[26,33,160,215,250,257,339,448,610,631],"recent":[27],"phase":[28,103],"1b":[29,104],"trial,":[30],"VenGilt":[31,100,158,285,399,505,523,525,617],"demonstrated":[32,262,418,496],"modified":[34],"complete":[35],"response":[36],"rate":[37],"75%":[39],"(Daver":[40],"et":[41],"al,":[42],"J":[43],"Clin":[44],"Oncol.":[45],"2022;":[46],"published":[47],"online).":[48],"However,":[49],"many":[50],"patients":[51],"(pts)":[52],"relapsed":[53],"after":[54,504],"VenGilt.":[55,210],"Proposed":[56],"resistance":[57,82,539,593,628],"mechanisms":[58],"include":[59],"RAS":[60,361,378,548,611,641],"pathway":[61,642],"mutations":[62,410,574],"(Ven":[63],"and":[64,66,119,234,278,326,369,427,440,470,489,516,520,572,600],"Gilt)":[65],"monocytic":[67,501,614,623],"immunophenotype":[68,624],"(Ven).":[69],"Using":[70],"single":[71,387,449],"cell":[72,388,450],"(SC)":[73],"multi-omic":[74,121,435],"profiling,":[75],"we":[76],"sought":[77],"to":[78,83,157,173,224,241,597,633],"identify":[79],"drivers":[80],"this":[84],"combination.":[85],"Methods:":[86],"We":[87,107,129,417],"analyzed":[88,130],"35":[89],"serial":[90,141,434],"samples":[91,118],"from":[92,136,295,559],"12":[93,137,202],"pts":[94,138,144,153,194,213,229,261,310,345,432,478,495],"R/R":[96],"AML":[97],"treated":[98],"on":[101,116,125,324,405,447],"trial":[105],"(NCT03625505).":[106],"performed":[108],"high-throughput":[109],"SC":[110,122,436,509],"DNA":[111],"sequencing":[112,374,510],"(Mission":[113],"Bio":[114],"Tapestri)":[115],"all":[117,201,245,292,493],"concurrent":[120],"cell-surface":[123],"immunophenotyping":[124],"18":[126],"samples.":[127],"Results:":[128],"107,528":[131],"cells":[132],"(median":[133,183],"8960":[134],"cells/pt)":[135],"2-5":[140],"timepoints.":[142],"Eight":[143],"had":[145,154,177,230,311,349,479],"previously":[146],"received":[147],"tyrosine":[148],"kinase":[149],"inhibitors":[150],"(TKI).":[151],"Nine":[152,260],"clinical":[155],"responses":[156],"median":[161],"relapse-free":[162],"time":[163,446],"8.3":[165],"mo.":[166],"Of":[167],"these":[168,476],"9":[169,218],"pts,":[170,203,291,320,333,394],"3":[171,290],"proceeded":[172],"transplant.":[174],"Each":[175],"pt":[176,248,337,354],"\u22651":[178,312,453,497],"genetically":[179],"distinct":[180],"clone":[181,253,498,578],"identified":[182],"4.5,":[184],"range":[185],"2-6).":[186],"Fourteen":[187],"FLT3mut":[188,198,205,221,395,413,426],"clones":[189,206,238,270,293,396,414,485,571],"were":[190,207,239,305,363,370,415,463,579],"detected,":[191],"2":[193,196,393,468],"having":[195,338],"separate":[197],"clones.":[199,429,473],"reduced":[208,240],"7":[212],"total":[216,367],"clones,":[219,233,268,531,606],"population":[222],"decreased":[223,357,401],"an":[225,263,626],"undetectable":[226,242,306,371],"level.":[227],"Three":[228],"FLT3-IDH1/2":[231],"co-mutated":[232,381],"double":[236],"mutant":[237],"levels":[243],"3.":[246],"One":[247],"developed":[249,613],"dominant":[251,328,340],"IDH2mut":[252,341],"at":[254,307,329],"relapse":[255,330],"without":[256],"co-mutation.":[259],"initial":[264],"decrease":[265],"non-FLT3mut":[267,287],"including":[269,424],"DNMT3A,":[272],"NPM1,":[273],"IDH1/2,":[274],"TET2,":[275],"EZH2,":[276],"WT1,":[277],"NRAS":[279],"mutations,":[280,549,594],"suggesting":[281,457],"some":[282],"activity":[283],"against":[286,529,602],"populations.":[288],"aside":[294],"those":[296,608],"associated":[297,541,580],"clonal":[299,518],"hematopoiesis":[300],"indeterminant":[302],"potential":[303],"(CHIP)":[304],"follow-up.":[308],"Five":[309],"pre-existing":[313,545],"NRAS-":[314],"or":[315,630,640],"KRAS-mutated":[316],"clone.":[317,342],"4/5":[319],"RASmutclone":[322,356],"expanded":[323,404],"therapy":[325],"was":[327,379,443,526,540],"3/4":[332],"fourth":[336],"All":[343],"4":[344,466],"expanding":[347],"RASmutclones":[348],"prior":[350,560],"TKI,":[351],"while":[352],"whose":[355],"did":[358],"not.":[359],"Pre-existing":[360],"populations":[362],"small":[364],"(0.001-18.1%":[365],"cells)":[368],"by":[372],"bulk":[373],"2/4":[376],"cases.":[377,391],"not":[380],"same":[386],"any":[390],"present":[397],"before":[398],"initially":[400],"but":[402],"subsequently":[403],"therapy.":[406],"No":[407],"de":[408,554],"novo":[409,555],"within":[411,455,575],"resistant/expanding":[412],"detected.":[416],"immunophenotypic":[419,481,502,517],"evolution":[420,521],"for":[421],"individual":[422],"genotypes,":[423],"both":[425,567],"FLT3WT":[428],"For":[430],"5":[431,477,494],"samples,":[437],"increased":[438,458,500,638],"CD11b":[439],"CD13":[441],"expression":[442],"observed":[444,464],"over":[445],"basis":[451],"genotype":[454],"individuals,":[456],"monocytic-like":[459],"features.":[460],"These":[461,583],"features":[462,503,615],"among":[465],"RASmut,":[467],"FLT3mut,":[469],"1":[471],"TET2mut":[472],"At":[474],"baseline,":[475],"heterogenous":[480],"profiles,":[482],"genetic":[484,515],"occupying":[486],"monocytic,":[487],"immature,":[488],"mixed":[490],"phenotypes;":[491],"however,":[492],"treatment.":[506,524],"Conclusion:":[507],"Multi-omic":[508],"enabled":[511],"direct":[512],"measurement":[513],"architecture":[519],"effective":[528],"even":[532],"presence":[535],"co-mutations.":[537],"Genetic":[538],"outgrowth":[543,568],"subclones,":[546],"primarily":[547],"rather":[550],"than":[551],"acquistion":[552],"mutations.":[556],"This":[557],"differs":[558],"studies":[561],"Gilt":[563],"monotherapy,":[564],"which":[566],"parallel":[570],"secondary":[573,592],"resistance.":[582],"data":[584],"suggest":[585],"addition":[587],"Ven":[589],"may":[590],"suppress":[591],"possibly":[595],"due":[596],"enhanced":[598],"apoptosis":[599],"cytotoxicity":[601],"cells.":[604],"Multiple":[605],"predominatly":[607],"mutation,":[612],"under":[616],"pressure.":[618],"It":[619],"unknown":[621],"whether":[622],"independent":[627],"mechanism":[629],"bystander":[632],"other":[634],"mechanisms,":[635],"such":[636],"as":[637],"MCL1":[639],"gene":[643],"expression.":[644],"Figure":[645],"1View":[646,649],"largeDownload":[647,650],"PPTFigure":[648],"PPT":[651],"Close":[652],"modal":[653]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}